Abstract:Context: Obstructive sleep apnea (OSA) has been increasingly implicated in the initiation and progression of cardiovascular diseases. Objective: To systematically review the interactions of OSA with cardiovascular pathophysiology and diseases. Data sources and study selection: The MEDLINE database from January 1966 to March 2003 was searched using the Medical Subject Headings sleep, sleep apnea, obesity, hypertension, heart failure, cardiac arrhythmia, coronary artery disease, stroke, sympathetic activity, endothelium, inflammation, and continuous positive airway pressure (CPAP) to identify peer-reviewed studies of OSA. Priority was given to large prospective cohort studies and to randomized controlled trials. Data extraction: We identified 154 original investigations and reviews of sleep-related breathing disorders. Data from these studies were examined for relevance and extracted by one of the authors. Data synthesis: Approximately 1 in 5 adults has at least mild OSA (apnea-hypopnea index [ie, the number of apneic and hypopneic events per hour], 5-15), and 1 in 15 adults has at least moderate OSA (apnea-hypopnea index, 15-30). Repetitive apneic events disrupt the normal physiologic interactions between sleep and the cardiovascular system. Such sleep fragmentation, as well as abnormalities evident in patients with OSA (eg, increased sympathetic activation, vascular endothelial dysfunction, increased oxidative stress, inflammation, increased platelet aggregability, metabolic dysregulation), may be implicated in the initiation and progression of cardiac and vascular disease. Persuasive data implicate OSA in the development of hypertension, and OSA also may contribute to cardiac ischemia, congestive heart failure, cardiac arrhythmias, and perhaps also to cerebrovascular disease and stroke. Conclusions: Obstructive sleep apnea is common, readily diagnosed, and usually treatable. It frequently coexists undiagnosed in patients with cardiovascular disease, activates disease mechanisms known to elicit cardiac and vascular damage, and may be implicated in progression of cardiovascular disease and resistance to conventional therapeutic strategies. In the absence of definitive evidence from large-scale trials and a better understanding of potential cost-effectiveness, the likely benefits of diagnosis and treatment of OSA are presently best appraised on an individualized patient basis.

Advances in Multimodal Echocardiographic Evaluation of Ischemic Cardiomyopathy due to Obstructive Sleep Apnea Syndrome

Progresses in Clinical and Basic Research of Myocardial Injury Caused by Obstructive Sleep Apnea

Study of Echocardiography Changes in Patients with Obstructive Sleep Apnea Syndrome

Association Between Obstructive Sleep Apnea and Cardiovascular Diseases.

Relationships Between Cardiometabolic Disorders and Obstructive Sleep Apnea: Implications for Cardiovascular Disease Risk

Impact of obstructive sleep apnea on prognosis of patients with cardiometabolic multimorbidity

Molecular Pathology, Oxidative Stress, and Biomarkers in Obstructive Sleep Apnea

Left ventricular remodeling and systolic function changes in patients with obstructive sleep apnea: a comprehensive contrast-enhanced cardiac magnetic resonance study

Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome

Cardiac Structural and Functional Changes in Old Elderly Patients with Obstructive Sleep Apnoea-Hypopnoea Syndrome

Cardiac autonomic dysfunction and structural remodeling: the potential mechanism to mediate the relationship between obstructive sleep apnea and cardiac arrhythmias

Left Ventricular Remodeling and Dysfunction in Obstructive Sleep Apnea

The Impact of Obstructive Sleep Apnea on Blood Pressure,Endothelial Function and Left Ventricular Mass

Evaluation of left ventricular function in obese patients with obstructive sleep apnea by three-dimensional speckle tracking echocardiography

Obstructive sleep apnea: implications for cardiac and vascular disease

The latest research progress on the relationship between obstructive sleep apnea–hypopnea syndrome and metabolic syndrome

[Progress in obstructive sleep apnea and atherosclerosis]

Impact of Obstructive Sleep Apnea and Sympathetic Nervous System on Cardiac Health: A Comprehensive Review

Investigating the Relationship between Obstructive Sleep Apnoea, Inflammation and Cardio-Metabolic Diseases

Impact of obstructive sleep apnoea on clinical characteristics and outcomes in patients with acute coronary syndrome following percutaneous coronary intervention.

An Update on Obstructive Sleep Apnea for Atherosclerosis: Mechanism, Diagnosis, and Treatment